Latest Expert Opinions

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
March 31, 2008
Not a company that weathered the major selloff since January, therefore not a great company. Look for companies that wont get hurt if a recession comes. Avoid this company.
Show full opinionHide full opinion
Not a company that weathered the major selloff since January, therefore not a great company. Look for companies that wont get hurt if a recession comes. Avoid this company.
BUY
BUY
March 31, 2008
Yield oriented companies make a lot of sense in this market. You wouldn’t want to see this stock trade below $37. Set $35 as a stop. Fundamentally the companies in pretty good shape. Could reach $45 in the next year.
Show full opinionHide full opinion
TC Energy (TRP-T)
March 31, 2008
Yield oriented companies make a lot of sense in this market. You wouldn’t want to see this stock trade below $37. Set $35 as a stop. Fundamentally the companies in pretty good shape. Could reach $45 in the next year.
WEAK BUY
WEAK BUY
March 31, 2008
The stock’s been consolidating since April last year. This could do pretty well. Likes steady growers in this environment, which this is. In this type of environment, outsourcing companies tend to do pretty well.
Show full opinionHide full opinion
CGI Group (A) (GIB.A-T)
March 31, 2008
The stock’s been consolidating since April last year. This could do pretty well. Likes steady growers in this environment, which this is. In this type of environment, outsourcing companies tend to do pretty well.
BUY
BUY
March 31, 2008
Would be a buyer of this stock. It’s performing really well. Comfortable holding it here. Likely to raise its dividend.
Show full opinionHide full opinion
Enbridge (ENB-T)
March 31, 2008
Would be a buyer of this stock. It’s performing really well. Comfortable holding it here. Likely to raise its dividend.
DON'T BUY
DON'T BUY
March 31, 2008
The pharma sector has had a rotten time, declining earnings. This company will have worst earnings than last year. Would avoid the stock (Not value investors, don’t try to pick bottoms), in a declining environment this will perform poorly.
Show full opinionHide full opinion
The pharma sector has had a rotten time, declining earnings. This company will have worst earnings than last year. Would avoid the stock (Not value investors, don’t try to pick bottoms), in a declining environment this will perform poorly.
VAGUE
VAGUE
March 31, 2008
A great play on economic strength in western Canada. Not inexpensive, probably the most expensive in Canada. They’re had tremendous growth. You’re fighting the tide with the financials.
Show full opinionHide full opinion
A great play on economic strength in western Canada. Not inexpensive, probably the most expensive in Canada. They’re had tremendous growth. You’re fighting the tide with the financials.
DON'T BUY
DON'T BUY
March 31, 2008
The company depends on being able to raise funding to buy assets. Over the last 9 months, the price people are willing to pay for assets has come down and the funding costs have increased. They are seeing a squeeze. Less attractive. Not the right stock for this type of environment.
Show full opinionHide full opinion
The company depends on being able to raise funding to buy assets. Over the last 9 months, the price people are willing to pay for assets has come down and the funding costs have increased. They are seeing a squeeze. Less attractive. Not the right stock for this type of environment.